about
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injuryHuman Validation of Genes Associated With a Murine Atherosclerotic Phenotype.Race/Ethnic Differences in the Associations of the Framingham Risk Factors with Carotid IMT and Cardiovascular Events.cNGR: a novel homing sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo.RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studiesEnabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs.Atherosclerotic expansive remodeled plaques: a wolf in sheep's clothing.Atherosclerotic plaque biomarkers: beyond the horizon of the vulnerable plaque.Circulating immunoglobulins are not associated with intraplaque mast cell number and other vulnerable plaque characteristics in patients with carotid artery stenosis.Expansive arterial remodeling: location, location, location.Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients.Ethnicity Modifies Associations between Cardiovascular Risk Factors and Disease Severity in Parallel Dutch and Singapore Coronary Cohorts.Functional role for toll-like receptors in atherosclerosis and arterial remodeling.Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort.Gender differences in health-related quality of life in patients undergoing coronary angiographyVascular remodeling and protease inhibition--bench to bedside.Carotid atherosclerotic plaque matrix metalloproteinase-12-positive macrophage subpopulation predicts adverse outcome after endarterectomy.Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes.Hematological Parameters Improve Prediction of Mortality and Secondary Adverse Events in Coronary Angiography Patients: A Longitudinal Cohort Study.Immune regulatory cells: circulating biomarker factories in cardiovascular disease.Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets.Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failureAberrant Splicing Promotes Proteasomal Degradation of L-type CaV1.2 Calcium Channels by Competitive Binding for CaVβ Subunits in Cardiac Hypertrophy.Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes: a case-control pilot study.10-years experience with the Athero-Express study.Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study.Leukotriene B4 levels in human atherosclerotic plaques and abdominal aortic aneurysms.Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular diseaseEndogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease.The innate immune response in reperfused myocardium.Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis.Women Undergoing Coronary Angiography for Myocardial Infarction or Who Present With Multivessel Disease Have a Poorer Prognosis Than Men.Biomarkers of Coronary Artery Disease Differ Between Asians and Caucasians in the General Population.Prevalence and Clinical Significance of Diabetes in Asian Versus White Patients With Heart Failure.Sex is associated with the presence of atherosclerotic plaque hemorrhage and modifies the relation between plaque hemorrhage and cardiovascular outcome.Soluble ST2 levels are not associated with secondary cardiovascular events and vulnerable plaque phenotype in patients with carotid artery stenosis.Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events.Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease.Histological features of carotid plaque in patients with ocular ischemia versus cerebral events.Temporal changes of soluble ST2 after cardiovascular interventions.
P50
Q28272621-F34C21A7-2FA9-4076-8C59-DD088822A6DAQ30276978-39EF15BA-18DB-4477-B701-2E233B100B32Q30279079-DFBFBB6F-6E9C-4BC9-99A7-8DB76CABA559Q30824450-FA4291F9-E11F-429E-8416-57F0D77FC664Q34097785-34745C79-93FD-4C29-B9DF-CAF62C07B591Q34999840-9F24C358-C0D9-4F2D-82DF-01C27C603EB5Q35059573-F957B16C-18A7-4057-8DF7-CC173F074AC2Q35092141-207DAAB7-4AC2-4572-8C47-9C1B98AF19C6Q35106514-04876CA9-E0A8-4126-9DA8-C23EE5BCB12CQ35649492-82F9995D-DDEC-4DBB-90FE-1C980267C49FQ35683559-5FE5084D-B075-4F13-B775-D18323D4D7FBQ35683772-701AA91A-6410-4F4B-845B-585F42799BF7Q35884631-0B4EFB3C-814E-4391-B96C-39DBDAA3AFD7Q35907034-B49B3802-AB76-4076-82E5-AE990A4C0F8BQ36012191-DDAEBAF4-1AAB-4932-8231-FACB19A5BD60Q36357530-C2DE0F64-8A73-476A-AEBD-DAB126ADF04BQ36519765-EF4BCF03-AB00-4B6F-BC22-027D9B730117Q36992432-EE255111-ABFF-47C0-AECE-815D1D30B069Q37016732-EEE61E18-AB07-44DC-95AC-354A04804E05Q37126720-26D9D40B-07E2-428C-828B-A7878BE30A26Q37160972-98D4CC7F-6023-40C6-8062-C3A73088D936Q37235817-609094D3-5742-4860-A73D-3770005CAF8CQ37330436-FC3BC510-811D-41B3-83E2-5DB6AFC2BB29Q37337753-CFF2A765-C89C-447A-84FC-6C9B6C1E054AQ37339333-AEC78BD9-DAF4-4FEA-9FAB-2A89055A0D60Q37517034-DEFA2FA1-FE0B-428C-8513-618732E272E9Q37520764-66BF4D25-3CA8-4E47-AF5E-3DA0BB08774EQ37568849-045A65DE-40C5-482B-BF53-19E835B96A15Q37739756-B1E1CDE2-02AB-4430-8EBE-AA5256584EC3Q37977824-9E9E8222-444D-4A39-9C41-74CD247AC1C0Q38106664-FA61A961-5785-4E85-AC0E-53C56BCE9AA1Q38404244-B618AEAE-B898-4054-BC73-B95226592084Q38503734-DE0CBFB0-C058-4F19-8FF4-83AF121DE9C9Q38817563-28BAF29B-C8C5-44E1-8B4C-EE38B1B62C34Q39331802-617F3CDE-E3E4-426F-A7DD-8BFDA368E424Q39332889-CBC3EB62-2569-4F69-B57A-44CD49821D6BQ39404175-409791A8-C1C7-4DB2-97C7-484719AA9D1AQ39452734-FAE04203-D942-4FD1-B551-5F31F0F1B536Q39476699-3DFBAA0D-5209-4D24-BE0F-458C404DD32FQ39507885-82C0A285-0FE0-48DC-A207-50A1AD84E642
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dominique P V de Kleijn
@ast
Dominique P V de Kleijn
@en
Dominique P V de Kleijn
@es
Dominique P V de Kleijn
@nl
type
label
Dominique P V de Kleijn
@ast
Dominique P V de Kleijn
@en
Dominique P V de Kleijn
@es
Dominique P V de Kleijn
@nl
prefLabel
Dominique P V de Kleijn
@ast
Dominique P V de Kleijn
@en
Dominique P V de Kleijn
@es
Dominique P V de Kleijn
@nl
P106
P1153
7003654548
P21
P31
P496
0000-0003-2714-2140